Summarized by Masters of Longevity from PR Newswire.
MoreBetter will co-invest its research platform in longitudinal patient-reported outcome studies.
Key Takeaways
- MoreBetter has committed to co-invest in ten studies.
- Each study is run with common validated instruments.
- Partners will receive de-identified longitudinal outcomes and adverse events.
